Ramm Pharma Corp.
Ramm Pharma Corp.
RAMM Pharma Corp., through its wholly-owned operating subsidiaries, is engaged in the pharmaceutical and medical product business, and is a leader in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. With RAMM’s large scale cultivation facility, the combined operations are expected to provide for complete vertical integration. Further to its industry leading activities in the cannabis sector, RAMM operates a pharmaceutical, cosmetic and nutraceutical product development and medical services business which has been servicing the local market for 30 years.
Ramm Pharma Corp. (RAMM)
SEDAR Information
Company Info
Capitalization
Company Officers
News Releases
Bulletins
2022-0328 - Reinstatement – Ramm Pharma Corp. (RAMM)
le 23 mars/March 2022
Effective immediately, Ramm Pharma Corp. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
____________________________
Avec effet immédiat, Ramm Pharma Corp. sera réintégré aux fins de négociation.
La Société a rectifié la situation de défaut ayant donné lieu à la suspension.
